Surrey Heartlands

Joint Formulary & PAD

Mavacamten - Cardiomyopathy

You are here : Home > Formulary Search > Mavacamten - Cardiomyopathy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD2
NICE
Restrictions / Comments :
Important

No local trust is a NHSE commissioned specialist cardiac centre

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mavacamten
Indication :
Cardiomyopathy
Group Name :
Keywords :
Brand Names Include :
Camzyos
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Mavacamten is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Cardiomyopathy.

  • No records returned.

Committee Recommendations (1)

06 Dec 23 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication